Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Fuhade Technology Development appears to be a corporate entity affiliated with Tasly Holding Group rather than a standalone drug-development biotech. Publicly accessible references identify it as a subsidiary of Tasly Holding Group in connection with Tasly BioPharmaceuticals and related shareholder matters. Because the available evidence is sparse, there is no clear public disclosure of an independent R&D pipeline, therapeutic targets, or specific clinical-stage assets directly under this entity's name. The broader Tasly group is active in biopharmaceuticals and pan-health businesses, but Tianjin Fuhade itself is best characterized as an affiliated operating or holding entity within that ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Fuhade Technology Development.